Recent Updates
Recently added Catalysts
MRNA Positive Sentiment

Moderna to Present at Upcoming Conferences in March 2026

Key Takeaway: Moderna, Inc. has announced its participation in two upcoming investor conferences in March 2026. The TD Cowen 46th Annual Healthcare Conference will take place on March 3, while the Barclays 28th Annual Global Healthcare Conference is scheduled for March 10. Both presentations will be available via live webcast and archived for 30 days on Moderna's website.
Price reaction · baseline $46.6 (2026-02-18 close) · hit pre-market · clean, no other MRNA news in the window
day 0 close
+6.7%
day 1
+7%
day 3 · peak
+8.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Moderna is actively engaging with investors through multiple conferences.
  • The company showcases its leadership in mRNA medicine.
  • Live webcasts of presentations enhance accessibility for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.1%
average across 3 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
mRNA-1645-eODGT8
Phase 1 · HIV Infections

Full Press Release Details

CAMBRIDGE, MASSACHUSETTS /ACCESS Newswire/ February 19, 2026 /Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
TD Cowen 46thAnnual Healthcare Conference, on Tuesday, March 3rdat 1:50pm ET
Barclays 28thAnnual Global Healthcare Conference, on Tuesday, March 10that 9:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website atinvestors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:Lavina TalukdarSenior Vice President & Head of Investor Relations617-209-5834Lavina.Talukdar@modernatx.com

SOURCE:Moderna, Inc.

Frequently Asked Questions

When is Moderna's presentation at the TD Cowen Conference?

Moderna will present at the TD Cowen 46th Annual Healthcare Conference on March 3, 2026.

Where can I watch Moderna's conference presentations?

Live webcasts of the presentations will be available on Moderna's Investors section of their website.

How long will the webcasts be available after the presentations?

The webcasts will be archived on Moderna's website for at least 30 days.

What is Moderna's focus in medicine?

Moderna is a leader in mRNA medicine, developing vaccines and therapeutics for various diseases.

Last updated: Feb 19, 2026